Clampdown of inflammation in aging and anticancer therapies by limiting upregulation and activation of GPCR, CXCR4
{{output}}
One of the major pathological outcomes of DNA damage during aging or anticancer therapy is enhanced inflammation. However, the underlying signaling mechanism that drives this is not well understood. Here, we show that in response to DNA damage, ubiquitously ex... ...
